These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16980337)

  • 21. In silico study of action potential and QT interval shortening due to loss of inactivation of the cardiac rapid delayed rectifier potassium current.
    Zhang H; Hancox JC
    Biochem Biophys Res Commun; 2004 Sep; 322(2):693-9. PubMed ID: 15325285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATX-II effects on the apparent location of M cells in a computational model of a human left ventricular wedge.
    Dos Santos RW; Otaviano Campos F; Neumann Ciuffo L; Nygren A; Giles W; Koch H
    J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S86-S95. PubMed ID: 16686688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pause induced early afterdepolarizations in the long QT syndrome: a simulation study.
    Viswanathan PC; Rudy Y
    Cardiovasc Res; 1999 May; 42(2):530-42. PubMed ID: 10533588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simulation study of cellular electric properties in heart failure.
    Priebe L; Beuckelmann DJ
    Circ Res; 1998 Jun; 82(11):1206-23. PubMed ID: 9633920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease.
    Zhang ZS; Tranquillo J; Neplioueva V; Bursac N; Grant AO
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H399-407. PubMed ID: 16877553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamical mechanisms of phase-2 early afterdepolarizations in human ventricular myocytes: insights from bifurcation analyses of two mathematical models.
    Kurata Y; Tsumoto K; Hayashi K; Hisatome I; Tanida M; Kuda Y; Shibamoto T
    Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H106-H127. PubMed ID: 27836893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
    Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model.
    Leoni AL; Gavillet B; Rougier JS; Marionneau C; Probst V; Le Scouarnec S; Schott JJ; Demolombe S; Bruneval P; Huang CL; Colledge WH; Grace AA; Le Marec H; Wilde AA; Mohler PJ; Escande D; Abriel H; Charpentier F
    PLoS One; 2010 Feb; 5(2):e9298. PubMed ID: 20174578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: A computational analysis.
    Wehrens XH; Abriel H; Cabo C; Benhorin J; Kass RS
    Circulation; 2000 Aug; 102(5):584-90. PubMed ID: 10920073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling gender effects on electrical activity of single ventricular myocytes.
    Cieniawa J; Baszak J; Olchowik G; Widomska J
    Comput Biol Med; 2013 Sep; 43(8):1063-72. PubMed ID: 23726761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simulation of Brugada syndrome using cellular and three-dimensional whole-heart modeling approaches.
    Xia L; Zhang Y; Zhang H; Wei Q; Liu F; Crozier S
    Physiol Meas; 2006 Nov; 27(11):1125-42. PubMed ID: 17028406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model.
    Hund TJ; Rudy Y
    Circulation; 2004 Nov; 110(20):3168-74. PubMed ID: 15505083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients.
    Ruan Y; Liu N; Bloise R; Napolitano C; Priori SG
    Circulation; 2007 Sep; 116(10):1137-44. PubMed ID: 17698727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling incomplete penetrance in long QT syndrome type 3 through ion channel heterogeneity: an in silico population study.
    Miller JA; Moise N; Weinberg SH
    Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H179-H197. PubMed ID: 36487185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.
    Makita N; Behr E; Shimizu W; Horie M; Sunami A; Crotti L; Schulze-Bahr E; Fukuhara S; Mochizuki N; Makiyama T; Itoh H; Christiansen M; McKeown P; Miyamoto K; Kamakura S; Tsutsui H; Schwartz PJ; George AL; Roden DM
    J Clin Invest; 2008 Jun; 118(6):2219-29. PubMed ID: 18451998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
    Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
    Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
    Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
    Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.